Scopolamine 1 mg/3d (Scopolamine PATCH) 1 mg/3d

Scopolamine 1 mg/3d transdermal patches provide motion sickness relief. Learn about uses, effects, and precautions for this medication.

Strength

1 mg/3d

Pack Size

24 POUCH in 1 CARTON (0378-6470-44) / 1 PATCH in 1 POUCH / 3 d in 1 PATCH

Manufacturer / TM Owner

Mylan Pharmaceuticals Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Scopolamine 1 mg/3d patches are commonly used for motion sickness prevention. These transdermal patches deliver scopolamine continuously over three days, helping to alleviate symptoms like nausea and vomiting associated with travel. People often ask, 'What is scopolamine used for?' beyond motion sickness, and it may also be used for other conditions as directed by a healthcare provider.

Side Effects

Common effects of scopolamine patches may include dry mouth, blurred vision, and drowsiness. Some users report dizziness or difficulty urinating. These effects vary by individual and typically subside as the body adjusts to the medication.

Precautions & Warnings

Handle scopolamine patches carefully, avoiding contact with eyes and skin irritation. Store them at room temperature, away from moisture and heat. Always follow the instructions provided with the medication to ensure safe and effective use.

Avoid Interactions

Scopolamine may interact with alcohol, increasing drowsiness and other side effects. It can also interact with other medications that affect the central nervous system. Always consult a healthcare provider before combining scopolamine with other treatments.

Frequently Asked Questions

Scopolamine is primarily used for preventing motion sickness and may also be used for other conditions as directed by a healthcare provider.

Scopolamine patches deliver the medication transdermally, releasing it continuously over three days to help prevent motion sickness.

Common side effects may include dry mouth, blurred vision, drowsiness, dizziness, and difficulty urinating.

Scopolamine may interact with other medications, especially those affecting the central nervous system. Always consult a healthcare provider before combining treatments.

Store scopolamine patches at room temperature, away from moisture and heat, and handle them carefully to avoid skin irritation.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.